Clinical Trials Browser

Phase 1/2 × Advanced Gastrointestinal Tumors × 90 days × Clear all

NCT04612712 2026-05-01

A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors

Phase 1/2 Terminated

Gastrointestinal

Advanced Gastrointestinal Tumors